Below is a comparison of today’s most prescribed GLP-1 medications, including Ozempic and Trulicity, both widely used for ...

The glucagon-like peptides (GLP-1 and GLP-2) are processed from the proglucagon polypeptide and secreted in equimolar amounts but have opposite effects on chylomicron (CM) production, with GLP-1 ...

Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) may protect against vertebral fractures in people with diabetes, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Dapiglutide was linked to weight loss at 13 weeks at ...

A study found patients with type 2 diabetes treated with GLP-1 receptor agonists were less likely to develop peptic ulcer disease (PUD). As a second-line therapy, GLP-1 drugs also appeared to be more ...

GLP-1 medicines have been utilised for the treatment of diabetes; however, they are now emerging as important topics for the treatment of obesity ...

Researchers are studying whether these widely used weight-loss drugs may also be future treatments for alcohol abuse.

The FDA has approved the first oral glucagon-like peptide-1 (GLP-1) receptor agonist for weight loss and to reduce the risk ...

Randomised trial data show GLP 1 receptor agonists are associated with increased risk of gallbladder and biliary disease, ...

Morrisons has partnered with Liverpool, U.K.-based sports nutrition, health and wellness brand Applied Nutrition on an ...

From cereal and granola to snacks and soda, Big Chalk’s Fall 2025 report outlines where GLP-1 users are cutting back - and ...